Insulin resistance associated to high levels of tumor necrosis factor (TNF) during pituitary apoplexy induced by a pituitary stimulating test in an acromegalic patient

Endocrinologist

Volumn 11, Issue 5, 2001, Pages 425-428

  Knoepfelmacher, Mirta ^a   Ursich, Milene ^a   Barros, Luciana M ^a   Duarte, Alberto ^a   Salgado, Luiz Roberto ^a   Pimentel Filho, Fernando ^a   Wajchenberg, Bernardo Leo ^a   Liberman, Bernardo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GONADORELIN; INSULIN; PROTIRELIN; TUMOR NECROSIS FACTOR;

ACROMEGALY; ADULT; ARTICLE; CASE REPORT; DOSE RESPONSE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOPHYSIS APOPLEXY; INSULIN RESISTANCE; MALE; PATHOGENESIS; POLYDIPSIA; POLYURIA; PROVOCATION TEST;

EID: 0034778572     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019616-200109000-00012     Document Type: Article

References (19)

1. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output
2. Effect of dexamethasone on insulin binding and glucose oxidation of isolated rat adipocytes
3. In vitro insulin resistance of human adipocytes isolated from subjects with non-insulin dependent diabetes mellitus
4. Acute degenerative changes in adenomas of pituitary apoplexy
5. Pathological report of a case of acromegaly with special reference to the lesions in the hypophysis and in thyroid gland: And a case of hemorrhage into the pituitary
6. Pituitary apoplexy
7. Pituitary apoplexy associated with a triple bolus test
8. Transient amaurosis and headache after thyrotropin releasing hormone
9. Pituitary apoplexy and sudden blindness following the administration of gonadotrophin releasing hormone
10. Pituitary growth hormone-secreting adenoma necrosis during an oral glucose tolerance test in acromegaly
11. Conservative management of pituitary apoplexy: A prospective study
12. Endocrine function after spontaneous infarction of the human pituitary: Report, review and reappraisal
13. Classical pituitary apoplexy: Clinical features, management and outcome
14. Tumor necrosis factor α inhibits signaling from the insulin receptor
15. Serum tumor necrosis factor alpha and insulin resistance in gastrointestinal cancer
16. Pituitary cytokine and growth factor expression and action
17. Cachectin alter anterior pituitary hormone release by a direct action in vitro
18. Cytokine expression in human anterior pituitary adenomas
19. Exercise and circadian rhythm induced variations in plasma cortisol differentially regulate interleukin-1β (IL-1β), IL-6 and tumor necrosis factor-α (TNFα) production in humans: High sensitivity of TNFα and resistance of IL-6